BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37550875)

  • 21. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
    Harris F; Tysome JR; Donnelly N; Durie-Gair J; Crundwell G; Tam YC; Knight RD; Vanat ZH; Folland N; Axon P
    Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auditory brainstem implants (ABIs)--20 years of clinical experience in Uppsala, Sweden.
    Siegbahn M; Lundin K; Olsson GB; Stillesjö F; Kinnefors A; Rask-Andersen H; Nyberg G
    Acta Otolaryngol; 2014 Oct; 134(10):1052-61. PubMed ID: 24881643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Auditory brainstem implants for hearing rehabilitation in NF2-schwannomatosis: A systematic review and single-arm meta-analysis.
    Wang B; Yan M; Liu C; Yang Z; Wang X; Zhao F; Wang Z; Li P; Wang Y; Li S; Liu G; Liu P
    NeuroRehabilitation; 2024; 54(2):213-225. PubMed ID: 38427506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auditory brainstem implantation in patients with neurofibromatosis type 2.
    Kanowitz SJ; Shapiro WH; Golfinos JG; Cohen NL; Roland JT
    Laryngoscope; 2004 Dec; 114(12):2135-46. PubMed ID: 15564834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
    Urban MJ; Moore DM; Kwarta K; Leonetti J; Rajasekhar R; Gluth MB; Wiet RM
    Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Compassionate use' protocol for auditory brainstem implantation in neurofibromatosis type 2: Early House Ear Institute experience.
    Roberts DS; Slattery WH; Chen BS; Otto SR; Schwartz MS; Lekovic GP
    Cochlear Implants Int; 2017 Jan; 18(1):57-62. PubMed ID: 28098509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Auditory brainstem implants in neurofibromatosis Type 2: is open speech perception feasible?
    Matthies C; Brill S; Varallyay C; Solymosi L; Gelbrich G; Roosen K; Ernestus RI; Helms J; Hagen R; Mlynski R; Shehata-Dieler W; Müller J
    J Neurosurg; 2014 Feb; 120(2):546-58. PubMed ID: 24329026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
    Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
    Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Cochlear Implantation in Neurofibromatosis Type 2 Related Hearing Loss.
    Sobczak G; Marchant W; Misurelli S; Pyle GM; Gubbels S; Roche J
    Ann Otol Rhinol Laryngol; 2023 Mar; 132(3):284-293. PubMed ID: 35450430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bilateral Auditory Brainstem Implants in Patients With Neurofibromatosis 2.
    Noonan KY; Rock J; Barnard Z; Lekovic GP; Brackmann DE; Wilkinson EP
    Otolaryngol Head Neck Surg; 2021 Aug; 165(2):339-343. PubMed ID: 33317418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial auditory and cognitive effects of auditory brainstem implantation in children.
    Colletti L
    Acta Otolaryngol; 2007 Sep; 127(9):943-6. PubMed ID: 17712673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hearing restoration with auditory brainstem implants after radiosurgery for neurofibromatosis type 2.
    Kalamarides M; Grayeli AB; Bouccara D; Dahan EA; Sollmann WP; Sterkers O; Rey A
    J Neurosurg; 2001 Dec; 95(6):1028-33. PubMed ID: 11765818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NF2-Related Intravestibular Schwannomas: Long-Term Outcomes of Cochlear Implantation.
    Jia H; Nguyen Y; Hochet B; Smail M; Mosnier I; Wu H; Sterkers O; Kalamarides M; Bernardeschi D
    Otol Neurotol; 2020 Jan; 41(1):94-99. PubMed ID: 31634276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hearing restoration in NF2 patients and patients with vestibular schwannoma in the only hearing ear: report of two cases.
    Ozdek A; Bayır O; Dönmez T; Ozışık P; Sahin M; Tulgar M; Tatar EÇ; Korkmaz MH
    Am J Otolaryngol; 2014; 35(4):538-41. PubMed ID: 24746329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.
    Tan H; Jia H; Li Y; Zhang Z; Zhu W; Cai Y; Wang Z; Wu H
    Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2667-2674. PubMed ID: 30229456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auditory brainstem implantation improves speech recognition in neurofibromatosis type II patients.
    Matthies C; Brill S; Kaga K; Morita A; Kumakawa K; Skarzynski H; Claassen A; Hui Y; Chiong C; Müller J; Behr R
    ORL J Otorhinolaryngol Relat Spec; 2013; 75(5):282-95. PubMed ID: 24042846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Awake craniotomy for assisting placement of auditory brainstem implant in NF2 patients.
    Zhou Q; Yang Z; Wang Z; Wang B; Wang X; Zhao C; Zhang S; Wu T; Li P; Li S; Zhao F; Liu P
    Acta Otolaryngol; 2018 Jun; 138(6):548-553. PubMed ID: 29361882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Auditory Brainstem Implantation: Candidacy Evaluation, Operative Technique, and Outcomes.
    Deep NL; Roland JT
    Otolaryngol Clin North Am; 2020 Feb; 53(1):103-113. PubMed ID: 31648821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A report of three cases and review of auditory brainstem implants in children].
    Couloigner V; Gratacap M; Ambert-Dahan E; Borel S; Ettienne V; Kerouedan A; Bouccara D; Zerah M; Kalamarides M; Sterkers O
    Neurochirurgie; 2014; 60(1-2):17-26. PubMed ID: 24656883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Auditory brainstem implantation].
    Hansen JO; West N; Bille M; Cayé-Thomasen P
    Ugeskr Laeger; 2021 Jan; 183(3):. PubMed ID: 33491645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.